Rallybio Corporation (RLYB)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Show:
Annual
Cash flow
All numbers in thousandsBreakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-76,275
-74,564
-66,654
-47,013
-26,447
-
Depreciation & amortisation
146
150
167
109
62
-
Stock-based compensation
9,963
10,920
9,499
3,645
704
-
Change in working capital
9,779
4,277
-936
-3,779
2,120
-
Accounts payable
-310
-99
487
-976
723
-
Other working capital
-56,969
-60,277
-57,338
-45,866
-22,176
-
Other non-cash items
-2,733
-3,089
-435
-
-
144
Net cash provided by operating activities
-56,957
-60,265
-57,284
-45,533
-22,039
-
Cash flows from investing activities
Investments in property, plant and equipment
-
-12
-54
-333
-137
-
Acquisitions, net
-2,250
-2,250
-300
-2,000
-1,935
-
Purchases of investments
-89,865
-108,414
-201,316
0
-
-
Sales/maturities of investments
128,584
138,334
89,500
0
-
-
Net cash used for investing activities
36,457
27,658
-112,170
-2,333
-2,072
-
Cash flows from financing activities
Common stock issued
-
0
51,533
86,200
145,205
-
Other financing activities
-
-139
-693
-3,233
-319
-
Net cash used provided by (used for) financing activities
282
143
51,078
82,967
144,886
-
Net change in cash
-20,218
-32,464
-118,376
35,101
120,775
-
Cash at beginning of period
39,519
56,958
175,334
140,233
19,458
-
Cash at end of period
19,301
24,494
56,958
175,334
140,233
-
Free cash flow
Operating cash flow
-56,957
-60,265
-57,284
-45,533
-22,039
-
Capital expenditure
-
-12
-54
-333
-137
-
Free cash flow
-56,969
-60,277
-57,338
-45,866
-22,176
-
© 2024 Yahoo. All rights reserved.